Cargando…
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
BACKGROUND: Docetaxel resistance remains a major obstacle in the treatment of non-small cell lung cancer (NSCLC). High-mobility group box 1 (HMGB1) has been shown to promote autophagy protection in response to antitumor therapy, but the exact molecular mechanism underlying HMGB1-mediated autophagy h...
Autores principales: | Pan, Banzhou, Chen, Dongqin, Huang, Jiayuan, Wang, Rui, Feng, Bing, Song, Haizhu, Chen, Longbang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125709/ https://www.ncbi.nlm.nih.gov/pubmed/24996221 http://dx.doi.org/10.1186/1476-4598-13-165 |
Ejemplares similares
-
TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-Resistant Lung Adenocarcinoma Cells
por: Chen, Jing, et al.
Publicado: (2019) -
MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma
por: Pan, Banzhou, et al.
Publicado: (2015) -
Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
por: Chen, Jing, et al.
Publicado: (2016) -
Mir-24-3p downregulation contributes to VP16–DDP resistance in small-cell lung cancer by targeting ATG4A
por: Pan, Banzhou, et al.
Publicado: (2014) -
Notch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes through AP-1/microRNA-451 Mediated Regulation of MDR-1
por: Huang, Jiayuan, et al.
Publicado: (2016)